Stay updated with breaking news from Disease Programs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Lexeo announces $95.0M equity financing, which in addition to 2023 year-end cash and cash equivalents of $121.5M, extends runway to fund operations into 2027 Reports frataxin protein expression data...
HOOKIPA to prioritize clinical development of HB-200 for the treatment of HPV16+ head and neck cancers and Gilead-partnered programs in infectious disease HOOKIPA will regain global development...
HOOKIPA to prioritize clinical development of HB-200 for the treatment of HPV16+ head and neck cancers and Gilead-partnered programs in infectious...
Services provided by the University of Georgia’s Cognitive Aging Research and Education Center (CARE) and the Athens Community Council on Aging (ACCA) are preparing to expand, seeking to address the
Completed enrollment of the LEAD Phase 1/2 clinical trial of LX1001 for the treatment of APOE4-associated Alzheimer’s disease